載入...
Increased Jab1/COPS5 is associated with therapeutic response and adverse outcome in lung cancer and breast cancer patients
Adjuvant chemotherapy has been established as standard treatment for advanced cancer among multidisciplinary therapies. A simple and instructive biomarker for therapeutic response and recurrence is needed to evaluate the therapeutic effect. Jab1/COPS5 level has been shown to be associated with tumor...
Na minha lista:
| 發表在: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Impact Journals LLC
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5722579/ https://ncbi.nlm.nih.gov/pubmed/29228627 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.22146 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|